Global Cannabis Applications Corp (GCAC) (CSE:APP, FRA:2FA, OTCQB:FUAPF), a leading developer of innovative data technologies for the cannabis industry, is pleased to announce the appointment of Rasool Verjee to its Advisory Board.
Mr. Verjee is a serial entrepreneur with a depth of experience in telecommunications and technology and an extensive, diverse global network.  His career has been marked by early adoption of emerging technologies delivering high returns on equity from start-up operations as evidenced by Telemagix, LavaLife Inc., and World Phone Inc.  He currently assists several companies planning to launch Initial Coin Offerings (ICOs) and is a partner in a Blockchain consultancy company.  He holds both a Bachelor of Laws and a Master in International Law from Cambridge University. 
Rasool Verjee will serve to provide guidance and forethought to the Company as it develops a purpose-built GCAC (Citizen Green) Blockchain to provide an immutable trust service for the global medical cannabis supply chain.  Mr. Verjee will work with GCAC’s management to define a framework that medical cannabis suppliers can use to secure their supply chain process on the GCAC Blockchain to share knowledge and build trust with medical cannabis regulators.  The GCAC Blockchain will also be used to create digital tokens for GCAC apps users to earn credits for engagement and information sharing on Prescriptti and CannaLife.
“As GCAC continues to expand its app data offering, we take great pleasure in having Mr. Verjee with his leadership in Blockchain and ICOs join the Advisory Board,” states GCAC’s CEO, Brad Moore.  
“Global Cannabis is taking medical cannabis data to the next level with their Blockchain development,” added Rasool Verjee.  “The incentivizing of app users with an ICO token and the use of smart contracts to encourage cannabis suppliers to participate is extremely innovative.”

About Global Cannabis Applications Corp.
Global Cannabis Applications Corp. is a global leader in designing, developing, marketing, and acquiring innovative data technologies for the cannabis industry.  Used globally, GCAC’s technologies facilitate the proliferation of digital conversations by like-minded people.  Managed by digital and cannabis industry experts, GCAC is focused on viral global expansion by providing the best digital experience in the cannabis market.  
 
For more information about the Company, please visit online at www.cannappscorp.com, or review its profiles on the SEDAR website (www.sedar.com) and on the Canadian Securities Exchange’s website (www.thecse.com)
 
To schedule an interview, please contact:
Bradley Moore
Chief Executive Officer
Telephone:  514-5619091
Email: bmoore@cannappscorp.com
 
For more information, please contact:
 
Corporate Communications
Telephone: 1.855.269.9554
Email: info@cannappscorp.com
www.cannappscorp.com
Forward-Looking Information
This news release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC.  Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC.  Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct.  Forward-looking statements contained in this news release are made as of the date of this news release.  GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
 
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information. 
Click here to connect with Global Cannabis Applications Corp (GCAC) (CSE:APP, FRA:2FA, OTCQB:FUAPF)) to receive an Investor Kit.

Source: www.irw-press.com


If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Keep reading... Show less

THC-O-Acetate to be Produced Through Company’s Specialty Molecule Division

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf”, “OILS”, or the “Company”), an extraction company that owns one of the largest portfolios of U.S. patents for the extraction and distillation of cannabinoids, is pleased to announce the launch of a Specialty Molecules Division to focus on the development and commercialization of novel psychoactive compounds. The division is supported by the Company’s existing intellectual property (“IP”) portfolio, including the manufacturing of CBD-O-acetate and the recently announced U.S. patent for the synthesis of THC-O-acetate.

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (the “Company”) is pleased to announce that it has completed construction of an industrial-grade distribution site and launched third party distribution services.

As part of its Phase 1 Construction project at the 196,000 square foot facility, the Company has built out 16,000 square feet of retail-ready product storage space, installed automated, assembly-line style packaging equipment for jar and pouch production, and built out a climate-controlled area that can store 30 tractor-trailer loads of cannabis and 230 pallets positions of -40 degree Fahrenheit freezers for storing live resin and live resin products. A secure loading bay and a small in-house fleet of refrigerated trucks is also in place.

Keep reading... Show less

Global Wellness Strategies Inc. (CSE: LOAN) (FSE: O3X) (OTCQB: PNNRF) (formerly Redfund Capital Corp.) (“GWS” or the “Company”) is pleased to provide the following corporate update highlights on two portfolio clients KaleidoMyco LLC and Biominerales Pharma Corp. and announces the signing of the one-stop digital marketing team of North Equities Corp.

“With the talent, skills and resources we have at Global Wellness, we are well positioned to develop leading nutraceutical product portfolio brands focused on health and well-being. As hemp-extract and psilocybin is legalized in more jurisdictions such as Oregon where we already have a strong strategic relationship, we can then easily extend our existing product range, which will already have established routes to market and brand recognition, to include myco-dosing products. KaleidoMyco products will be in stores and on a consumer digital platform in the USA shortly and is currently being consumer tested in Europe as well. Our shareholders and customers are extremely important to us and we look forward to meeting the milestones we have outlined with the help of North Equities,” said Meris Kott, CEO.

Keep reading... Show less

VINIA(R)’s ability to increase dilation of arteries and to reduce blood vessel constriction allows it to fight the human aging process

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) announces that its flagship VINIA® product is the only dietary supplement available in the US market which has the capability for both reducing the endothelin 1 (ET1) enzyme as well as increasing the nitric oxide (NO) molecules, in order to increase the dilation of arteries and thereby improve blood flow. The presence of ET1 constricts the blood vessel, whereas the presence of NO dilates it. As a result of its “double-action” effect (proven by the Flow Mediated Dilatation (FMD) measurements in a double-blinded Placebo-controlled clinical trial*and in an in-vitro study** whose results were both published), VINIA® is uniquely positioned to combat the aging process caused by a reduction in blood flow.

Keep reading... Show less